Conference
EFMC-ASMC 2025
- August 31st – September 4th, 2025
- Porto, Portugal
Schrödinger is excited to be participating in the EFMC-ASMC 2025 conference taking place on August 31st – September 4th in Porto, Portugal. Join us for a poster presentation by David Papin, Principal Scientist II at Schrödinger, titled “In silico enabled discovery of KAI-11101, a preclinical DLK inhibitor for the treatment of neurodegenerative disease and neuronal injury.” Stop by booth 11 to speak with Schrödinger scientists.
In silico enabled discovery of KAI-11101, a preclinical DLK inhibitor for the treatment of neurodegenerative disease and neuronal injury
Speaker:
David Papin, Principal Scientist II, Schrödinger